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Background: The re-emergence of syphilis among HIV-positive gay and other men who have sex with men (MSM)
requires vigilance. We estimated incidence of and risk factors for first and subsequent syphilis diagnoses among
MSM in HIV care in Ontario, Canada.
Methods: We analyzed data from 2,280 MSM under follow-up from 2006 to 2010 in the Ontario HIV Treatment
Network Cohort Study (OCS), a multi-site clinical cohort. We obtained syphilis serology results via record linkage
with the provincial public health laboratory. Rates were calculated using Poisson regression.
Results: First syphilis diagnoses occurred at a rate of 2.0 per 100 person-years (95 % CI 1.7, 2.4; 121 cases) whereas
the re-diagnosis rate was 7.5 per 100 person-years (95 % CI 6.3, 8.8; 136 cases). We observed higher rates over time
and among men who were aged <30 years, receiving care in the two largest urban centers, or had a previous
syphilis diagnosis. Syphilis diagnosis was less common among Indigenous men, men with higher CD4 cell counts,
and, for first diagnoses only, among men with less than high school education.
Conclusions: Compared to reported cases in the general male population, incidence of a new syphilis diagnosis was
over 300 times greater among HIV-positive MSM but year-to-year changes reflected provincial trends. Re-diagnosis was
common, suggesting treatment failure or re-infection. Novel syphilis control efforts are needed among HIV-positive MSM.Background
After years of decline, many urban centres have reported
concerning rises in case reports of infectious syphilis in
North America, Europe, Australia, and Asia [1–5]. Un-
treated, infections enter an asymptomatic latent stage that
can last for many years; potential complications include
tissue destruction of any organ [6] including neurosyphilis,
a potentially life threatening complication [7]. Local epi-
demiology suggests that these outbreaks are largely occur-
ring among gay and other men who have sex with men
(MSM). In Ontario, Canada, reports of infectious syphilis
rose from 0.4 to 5.9 cases per 100,000 from 2001 to 2012,
with virtually all (96 %) cases among males [8]. Most male* Correspondence: ann.burchell@utoronto.ca
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article, unless otherwise stated.cases (88 %) reported sex with other men and HIV co-
infection was noted in 40 % of cases [1]. In contrast, HIV
prevalence is 23 % and 11 % among MSM in Toronto and
Ottawa, respectively [9, 10], suggesting over-representation
of HIV-positive men in syphilis transmission networks.
Internationally, higher rates of bacterial STI infection have
been noted among HIV-positive compared to HIV-negative
MSM [11–13]. Nevertheless, we are unaware of published
reports of syphilis incidence in HIV-positive MSM popula-
tions in our setting or elsewhere in Canada.
Investigation of syphilis incidence requires consideration
of re-infection to fully characterize the patterns of
population-level transmission and to design interventions.
New syphilis cases among HIV co-infected men commonly
have a past history of previous syphilis infection [8, 14, 15].
Epidemiological characterization of the rate of first versus
subsequent syphilis infections could help to determine tocle is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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groups experiencing repeated infections.
Our primary objectives were to estimate the incidence of
first and subsequent syphilis diagnoses in a large cohort of
HIV-positive MSM and to identify risk factors for these
diagnoses. As we had full access to syphilis test results but
were challenged by incomplete recording of syphilis staging
information in medical charts, a secondary objective was to
evaluate the use of laboratory-based definitions for their
potential in monitoring rates of new syphilis diagnoses.
Methods
We analyzed data from the Ontario HIV Treatment Net-
work Cohort Study (OCS). The province of Ontario has
publicly-funded, universal access to medically-necessary
health care services. An estimated 32,547 Ontarians have
been infected with HIV since reporting began in 1985 up to
the end of 2011; 77 % were men who reported sex with
men as their potential route of HIV acquisition [16]. We
have previously described the study design [17]. Briefly, the
source population consisted of people aged 16 and older
diagnosed with HIV infection and who received specialty
HIV care at one of 10 hospital- or community-based prac-
tices. Approximately 43 % of clinic patients were active
participants (range 20–79 % across clinics) [17]. Partici-
pants provided written consent. Clinical data recorded as
part of participants’ routine health care were abstracted
from medical records. Beginning in 2007, participants were
interviewed annually using structured questionnaires. The
study protocol and instruments received ethical approval
from the University of Toronto Human Subjects Review
Committee and from the individual study sites.
Viral load and syphilis testing
We obtained laboratory data for HIV viral load and syphilis
through record linkage with the Public Health Ontario
Laboratories, the sole provider of such testing in Ontario.
Serology is the primary diagnostic methodology used for
syphilis testing. Since 2006, the testing algorithm includes
screening with a treponemal test, the Abbott chemilumin-
escent immunoassay (CMIA), followed by confirmatory
testing with the RPR, TPPA, and FTA-ABS tests [18]. To
ensure comparability of results across years, we excluded
person-time for years prior to 2006.
Incidence definitions
We calculated the annual incidence density of syphilis diag-
noses. We use the term “diagnosis” rather than “infection”
because syphilis tests were ordered based on clinical deci-
sions rather than standardized testing protocols and inter-
vals between tests varied, both of which would tend to
underestimate true infections. A similar approach was used
in the province of British Columbia, Canada [15]. Incident
cases were defined using syphilis serologic results only. Wepreviously reported that medical chart data were insuffi-
cient for staging among the majority (57 %) of patients
whose serology suggests active infection [19].
Men who had a negative serology result in 2006–2010
were eligible for inclusion in the calculation of incidence of
a first diagnosis of syphilis. The denominator was person
time beginning at the first negative test or year immediately
following HIV diagnosis, whichever was later. The numer-
ator was the number of men with subsequent reactive
syphilis serology.
Men with a reactive syphilis serology test were considered
at risk for re-diagnosis at the first non-acute rapid plasma
reagin (RPR) test (≤1:8) in 2006–2010, or the year immedi-
ately following HIV diagnosis, whichever was later. Men di-
agnosed with syphilis during follow-up were considered at
risk for re-diagnosis beginning 120 days after the previous
event, under the assumption that all would have received
adequate treatment by such time given clinical guidelines
[6] and average frequencies of HIV care in our cohort. In
sensitivity analyses, we varied the timing of re-entry to the
risk set at 90, 120, 150 or 180 days after the previous diag-
nosis. These intervals were more stringent than previous
research that considered cases at risk of a new diagnosis
within 42 days [15]. Our primary definition was a four-fold
rise in RPR titre. In sensitivity analyses, we used a more
conservative definition requiring a four-fold rise in titre to
1:16 or greater.
Left- and right-censoring was applied to incidence calcu-
lations. For men who were diagnosed with HIV in 2006 or
later, we left-censored and excluded person-time in years
up to and including the year of HIV diagnosis because we
wished to exclude syphilis detected prior to or concomitant
with HIV diagnosis. Men who were lost-to-follow-up were
right-censored as of their last known clinic visit and men
known to have died were censored at the date of death; all
others were censored on December 31, 2010.
Analysis
We analyzed data available as of December 2011, at which
time 5933 participants had enrolled. We restricted the
analysis to participants under observation at any time from
2006 to 2010 (1,686 excluded), for whom there was
successful record linkage to the HIV viral load database at
the PHOL (260 excluded), and who were men who either
self-identified as gay or bisexual or reported sex with men
as an HIV risk factor (n = 2,775 men). The year 2011 was
excluded to maximize availability of clinical data as manual
chart reviews were incomplete for that year. We further
restricted the sample to men who had at least one syphilis
test in 2006–2010 (429 excluded), who were diagnosed with
HIV prior to 2010 (13 excluded), and who contributed
person-time to either the calculation of first or re-diagnosis
(62 excluded). The final sample size was 2,271 MSM. We
conducted all statistical analyses using SAS version 9.3
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two-sided. Statistical significance was determined using the
conventional p-value of < 0.05.
We first used descriptive statistics to characterize men
included in the analyses of first and re-diagnosis with
syphilis according to their age, year of HIV diagnosis,
race/ethnicity, education, income, region of Ontario,
clinical and antiretroviral treatment status.
Next we calculated and compared annualized incidence
densities using Poisson regression and time-updated
covariates in PROC GENMOD. To account for recurrent
events, we used a generalized estimating equations (GEE)
framework with an auto-regressive correlation structure.
This approach adjusts standard errors for correlation
among repeated observations within individuals. We mod-
eled the total number of events using an offset for the
number of person-years of follow-up time. We used
intercept-only models to estimate crude rates with 95 %
confidence intervals. We conducted separate analyses for
first and re-diagnoses (including a sensitivity analysis
using our more conservative definition of re-diagnosis), as
well as a combined analysis of the incidence of syphilis
diagnosis, for which first and subsequent events were
counted equally.
Rates were compared using incidence rate ratios (RR)
calculated by exponentiating the parameter estimates. We
analyzed calendar time as a categorical and continuous
variable to verify whether the association was linear. Race/
ethnicity, education and income were analyzed as time-
invariant variables. Age, region, viral load, CD4 cell count,
and antiretroviral treatment status were time-updated each
calendar year. All considered covariates were included in
the final model; observations with missing data on covari-
ates were excluded. To evaluate evidence for differences in
risk factors for first or subsequent syphilis diagnosis, we
tested the statistical significance of an interaction term
between the risk factor of interest with an indicator variable
for past syphilis diagnosis.
To further address our secondary objective to evaluate
the use of laboratory-based definitions for their potential in
monitoring rates of new syphilis diagnoses, we wished to
compare our estimated rates in the cohort to population-
based rates with specific attention to temporal trends. The
ideal comparison would be syphilis rates among the entire
population of MSM in Ontario but such data were unavail-
able. Therefore, we compared our observed rates to those
that were available via public health surveillance, namely
population-based rates of reported infectious syphilis
among males in Ontario [20].
Results
At baseline, the 2,271 men were aged 46 years, on average
(Table 1). The majority self-identified as gay, were of white
race/ethnicity, had been diagnosed with HIV prior to 2006,and received HIV care in Toronto, the largest city in the
province. Most (83.8 %) had initiated antiretroviral treat-
ment. Nearly two-thirds had undetectable HIV viral load
and the mean CD4 cell count was 497 cells/mm3. Partici-
pants were followed a median of 2.5 years for a sum total
of 7,275 person-years. Men included in the analysis of
syphilis re-diagnosis were largely similar to men included in
the analysis of first diagnosis, with some exceptions
(Table 1). Among men with documented past syphilis who
were at risk for re-diagnosis, a greater proportion self-
identified as gay and received care in Toronto; they were
also slightly older at baseline (mean 47.1 versus 45.2 years,
P <0.0001).First syphilis diagnosis
Among the 1,799 men with initially negative serology, first
syphilis diagnoses occurred at a rate of 2.0 per 100 person-
years (95 % CI 1.7, 2.4; 121 cases). Incidence increased on
average 17 % per calendar year with the highest rate ob-
served in 2009 (Fig. 1; Table 2). We observed statistical evi-
dence of rate differences according to age, region, and
education, such that the highest rates were among young
men under the age of 30, men receiving care in Toronto,
and men with more than high school education (Table 3).Re-diagnosis of syphilis
Among the 586 men with reactive serology indicative
of past syphilis infection, there were 136 case events
among 114 men using our primary definition of re-
diagnosis, i.e., a four-fold rise in RPR titre. Among
men with a re-diagnosis, most (82 %) had one, 16 %
had two, and 2 % had three re-diagnoses of syphilis.
Incidence of re-diagnosis was 7.5 per 100 person-years
(95 % CI 6.3, 8.8) if all 136 cases were considered re-
diagnoses. Eighty-four percent of case events (114/
136) met our more conservative definition of re-
diagnosis of a four-fold rise in titre to at least 1:16; on
average, the titre rose to 1:64 (IQR 1:16 – 1:128). As
expected, incidence was somewhat lower at 6.2 per 100
person-years (95 % CI 5.2, 7.5) when using the conservative
re-diagnosis definition. Case counts for re-diagnosis were
virtually unchanged with varying time of re-entry to the risk
set (range 134–137 cases for our primary re-diagnosis
definition; range 112–115 cases for re-diagnosis using the
more conservative definition). Incidence of re-diagnosis
increased an average of 36 % per calendar year with the
highest rate observed in 2010 (Fig. 1; Table 3).
As for rates of first diagnosis, re-diagnosis rates were
higher among younger men and men receiving care in To-
ronto (Table 3). However, there was no difference accord-
ing to education. Rate ratios were largely unchanged when
we used our more conservative definition of re-diagnosis
(data not shown).
Table 1 Characteristics of HIV-positive MSM included in the analysis, OHTN Cohort Study, 2006–2010
Analysis of first syphilis diagnosis Analysis of syphilis re-diagnosis Combined analysis of new syphilis diagnosis
n % n % n %
Total N 1799 100 586 100 2271 100
Mean age at baseline (SD) (a) 45.2 9.2 47.1 10.5 45.9 9.5
Sexual orientation
Gay 1360 75.6 493 84.1 1752 77.1
Bisexual 129 7.2 27 4.6 151 6.6
Heterosexual 75 4.2 7 1.2 81 3.6
Unknown (b) 235 13.1 59 10.1 287 12.6
Race
White 1311 72.9 423 72.2 1654 72.8
Black/African 54 3 27 4.6 77 3.4
Multiple 138 7.7 52 8.9 177 7.8
Indigenous 111 6.2 20 3.4 126 5.5
Other 116 6.4 51 8.7 157 6.9
Unknown 69 3.8 13 2.2 80 3.5
Education (c)
High school or less 395 22 111 18.9 493 21.7
Trade school or college 498 27.7 179 30.5 633 27.9
University 680 37.8 242 41.3 871 38.4
Unknown (b) 226 12.6 54 9.2 274 12.1
Annual personal income (c)
Less than $20,000 CDN 565 31.4 188 32.1 716 31.5
$20,000 to $59,999 CDN 631 35.1 213 36.3 799 35.2
$60,000 CDN or more 353 19.6 122 20.8 452 19.9
Unknown (b) 250 13.9 63 10.8 304 13.4
Region where receiving HIV care
Toronto 1224 68 474 80.9 1598 70.4
Ottawa 193 10.7 50 8.5 237 10.4
Elsewhere in Ontario 382 21.2 62 10.6 436 19.2
Year of HIV diagnosis
Median (IQR) 1997 (91,03) 1997 (91,03) 1996 (91,03)
Diagnosed in 2006–09 177 9.8 56 9.6 214 9.4
Clinical status at baseline (a)
Initiated antiretroviral treatment 1952 86.0 1546 85.9 491 83.8
Mean CD4 cell count/mm3 (SD) 497.1 261.6 491.3 252.4 497.1 261.6
Undetectable viral load (d) 1173 65.2 363 61.9 1473 64.9
MSM Men who have sex with men, SD Standard deviation, IQR Interquartile range
(a) Baseline was the later of January 1, 2006 or the date of enrolment in the cohort
(b) Unknowns include men who were not interviewed
(c) As reported at the participant’s first interview in 2007–2010, available for 1967/2271 men
(d) Undetectable viral load defined as <50 copies/mL in 2006–2009 and <40 copies/mL in 2010
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Overall, incidence of a new syphilis diagnosis (first
documented diagnosis or subsequent diagnosis) was
3.3 per 100 person-years (95 % CI 2.9, 3.7; 257 cases)with a trend for increasing incidence over time (Fig. 1;
Table 3). Men with a history of previous syphilis were at
greater risk of a new syphilis diagnosis compared to men
with no such history (adjusted RR = 3.5, 95 % CI 2.2, 5.8).
There was evidence of modest within-subject correlation
Fig. 1 Rate of new syphilis diagnoses among HIV-positive MSM,
OHTN Cohort Study, 2006–2010. Re-diagnosis defined as a four-fold
rise in RPR titre. See text for details
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1 year apart). Among cases, 22 % were among men who
had previously had syphilis.
Risk factors for any new syphilis diagnosis were con-
sistent with those observed in separate analyses of first
and re-diagnoses. Although Indigenous men had the
lowest rates of first and re-diagnoses, it was only in the
combined analysis that the difference had adequate
precision to reject the null hypothesis (adjusted RR =
0.25, 95 % CI 0.06, 0.97). Similarly, the relation between
increasing CD4 cell count and lower incidence of syph-
ilis diagnosis was sufficiently precise to rule out chance
association only in the combined outcome model.
Education was the sole risk factor showing statistical
evidence of effect modification. Compared to men with
university education, men with high school education
or less were less likely to have a new diagnosis of syph-
ilis if they had no previous history of syphilis (adjusted
RR = 0.42, 95 % CI 0.25, 0.73); however, the rate ratio
was null among men with a past history of syphilis
(adjusted RR = 1.4, 95 % CI 0.69, 8.4; P-value for inter-
action = 0.04).Table 2 Rates of new syphilis among HIV-positive MSM in the OCS
HIV-positive MSM, OHTN Cohort Study (OCS)
Year Rate of first diagnosis
per 100PY (95 % CI)
Rate of re-diagnosis per
100PY (95 % CI) (b)
Rate of any new
diagnosis per 100PY
(95 % CI)
2006 1.2 (0.6, 2.5) 4.0 (1.9, 8.4) 1.8 (1.1, 3.0)
2007 1.7 (1.1, 2.7) 3.2 (1.8, 5.8) 2.1 (1.5, 2.9)
2008 1.4 (0.9, 2.1) 6.7 (4.6, 9.8) 2.6 (1.9, 3.4)
2009 3.3 (2.5, 4.4) 9.0 (6.6, 12.3) 4.7 (3.8, 5.8)
2010 2.0 (1.4, 2.9) 10.9 (8.3, 14.4) 4.3 (3.5, 5.4)
PY Person-years, CI Confidence interval
(a) Population-based rates of reported infectious syphilis among males in Ontario, C
(b) Re-diagnosis defined as an observable four-fold rise in RPR titre. See text for detHIV viral load among cases
We characterized HIV viral load patterns among all 257
new syphilis cases. For the test on or immediately preceding
the date of syphilis diagnosis, 59 % had undetectable viral
load, 8 % had detectable but low-level viremia (<1,000 cop-
ies/mL), 29 % had a viral load between 1,000 and 100,000
copies/mL, and 4 % had a viral load >100,000 copies/mL.
Among cases with detectable viral load, 52 % (65/126) had
been taking antiretroviral medications according to their
medical chart records.
Discussion
Among gay and other MSM in HIV care in Ontario,
Canada, the rate of new syphilis diagnoses rose from 1.8
per 100 person-years in 2006 to 4.3 per 100 person-years in
2010. These rates are over 300 times greater than those re-
ported for the general male population in Ontario over the
same period [1], but are consistent with those observed
internationally among HIV-positive MSM, including in the
United States [21], Australia [12] and Europe [11, 22]. Im-
portantly, the rates we documented in the cohort are
under-estimates since they were measured in routine prac-
tice rather than by active screening programs.
Strengths of our analysis include a large sample of HIV-
positive men with known sexual orientation and record
linkage with syphilis serology results from the sole labora-
tory that conducts such testing for the province. Although
a high proportion of reported syphilis cases in our setting
have been identified as HIV-positive MSM [8], our findings
advance knowledge by calculating rates of new syphilis
diagnosis—first and re-diagnoses—using a known denom-
inator that was well characterized according to sociodemo-
graphic, HIV risk, and clinical features.
Potential limitations include under-ascertainment of
true syphilis infection due a lack of standardized testing
practice and selection bias due to volunteer participa-
tion. Only 55 % of MSM in the cohort undergo syphilis
testing at least once a year [19]. We may have inaccur-
ately classified “first” syphilis diagnoses because as many as
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Table 3 Risk factors for a new diagnosis of syphilis among HIV-positive MSM, OHTN Cohort Study, 2006–2010
First syphilis diagnosis Re-diagnosis of syphilis (a) Any new syphilis diagnosis




Rate per 100PY (95 % CI) Adjusted RR
(95 % CI)
Rate per 100PY (95 % CI) Adjusted RR
(95 % CI)
Time (1-year increase) 1.3 (1.1, 1.5) 1.4 (1.2, 1.6) 1.3 (1.1, 1.4)
Age
<30 years 6.8 (4.2, 11.1) 4.5 (1.9, 10.3) 18.7 (10.9, 32.3) 3.7 (1.9, 7.2) 9.5 (6.6, 13.7) 3.0 (1.7, 5.4)
30–49 years 2.2 (1.8, 2.7) 1.7 (1.0, 2.9) 9.8 (8.0, 12.0) 2.4 (1.6, 3.7) 3.7 (3.2, 4.3) 1.6 (1.1, 2.3)
50+ years 1.1 (0.7, 1.7) 1.0 3.8 (2.7, 5.4) 1.0 1.9 (1.5, 2.5) 1.0
Race
White 1.9 (1.6, 2.4) 1.0 7.4 (6.1, 9.0) 1.0 3.2 (2.8, 3.7) 1.0
Black 2.3 (0.8, 6.0) 0.9 (0.3, 2.6) 7.8 (3.5, 17.3) 0.8 (0.4, 1.8) 3.9 (2.1, 7.3) 1.0 (0.5, 1.8)
Indigenous 0.8 (0.3, 2.5) 0.2 (0.02, 1.3) 1.9 (0.3, 13.6) 0.4 (0.1, 2.8) 0.9 (0.4, 2.5) 0.25 (0.06, 0.97)
Other/unknown 2.8 (1.9, 4.0) 1.1 (0.7, 1.8) 8.3 (5.8, 11.9) 0.9 (0.5, 1.4) 4.2 (3.2, 5.4) 0.9 (0.6, 1.3)
Education
High school or less 0.9 (0.5, 1.6) 0.4 (0.2, 0.8) 5.7 (3.7, 8.8) 0.8 (0.4, 1.4) 1.9 (1.4, 2.7) (b)
Trade school or college 2.7 (2.0, 3.6) 1.0 (0.6, 1.6) 8.9 (6.8, 11.8) 1.1 (0.7, 1.7) 4.2 (3.5, 5.2)
University 2.4 (1.8, 3.1) 1.0 7.5 (5.8, 9.7) 1.0 3.6 (3.0, 4.4)
Annual personal income
Less than $20,000 CDN 1.9 (1.4, 2.7) 1.1 (0.6, 2.0) 7.7 (5.8, 10.3) 0.8 (0.5, 1.4) 3.3 (2.7, 4.1) 1.2 (0.8, 1.8)
$20,000–$59,999 CDN 2.3 (1.7, 3.0) 1.1 (0.7, 1.9) 6.7 (5.0, 8.9) 0.6 (0.4, 1.0) 3.3 (2.7, 4.1) 0.9 (0.6, 1.4)
$60,000 CDN or more 1.9 (1.3, 2.9) 1.0 9.4 (6.8, 12.9) 1.0 3.7 (2.9, 4.8) 1.0
Region receiving HIV care
Toronto 2.6 (2.2, 3.1) 4.0 (1.6, 10.3) 8.4 (7.0, 10.0) 2.9 (0.9, 9.0) 4.1 (3.6, 4.7) 4.7 (2.1, 10.6)
Ottawa 1.1 (0.5, 2.6) 0.7, (0.1, 6.4) 3.1 (1.2, 8.3) 1.2 (0.3, 5.2) 1.5 (0.8, 2.9) 2.2 (0.7, 7.0)
Elsewhere in Ontario 0.4 (0.2, 1.0) 1.0 3.1 (1.4, 6.9) 1.0 0.8 (0.4, 1.4) 1.0
Maximum viral load in year
Detectable 2.9 (2.2, 3.7) 1.3 (0.8, 2.3) 8.8 (6.9, 11.1) 1.0 (0.6, 1.5) 4.4 (3.7, 5.3) 1.1 (0.8, 1.6)
Undetectable 1.6 (1.2, 2.1) 1.0 7.0 (5.5, 8.8) 1.0 2.8 (2.3, 3.3) 1.0
Minimum CD4 in calendar year
<350 cells/mm3 2.1 (1.5, 2.9) 8.4 (6.4, 11.1) 3.7 (3.0, 4.5)
350–499 cells/mm3 2.6 (1.9, 3.5) 9.0 (6.7, 12.2) 4.1 (3.3, 5.1)
500 cells/mm3 or greater 1.5 (1.0, 2.1) 6.4 (4.7, 8.7) 2.6 (2.0, 3.2)
Per 100 unit increase 0.93 (0.85, 1.01) 0.93 (0.85,1.0) 0.92 (0.86, 0.99)
On antiretroviral treatment
Yes 1.7 (1.4, 2.4) 0.9 (0.5, 1.7) 7.0 (5.8, 8.5) 0.8 (0.5, 1.4) 2.9 (2.5, 3.4) 0.9 (0.6, 1.3)
No 3.8 (2.7, 5.4) 1.0 9.6 (6.6, 13.7) 1.0 5.3 (4.1, 6.8) 1.0
Past syphilis diagnosis
Yes 19.7 (14.8, 26.2) 3.5 (2.2, 5.8)
No 2.8 (2.4, 3.2) 1.0
PY Person years, CI Confidence interval, RR Rate ratio calculated using Poisson regression adjusted for all variables shown
(a) Re-diagnosis defined as a four-fold rise in RPR titre. See text for details
(b) In the analysis of any new syphilis diagnosis, there was a statistically significant interaction between education and history of past syphilis diagnosis (P = 0.04).
Adjusted RRs (95 % CI) for education level among men with no past syphilis diagnosis were 0.42 (0.25, 0.73) for high school or less and 0.88 (0.62, 1.3) for trade
school/college compared to men with university. Among men with a past syphilis diagnosis, the adjusted RRs were 1.4 (0.69, 8.4) for high school or less and 1.3
(0.71, 2.3) for trade school/college compared to men with university
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ilis diagnoses would not have been affected by false
classification of re-diagnoses as “first” diagnoses since
both were counted equally. Cohort participants are
generally representative of HIV diagnoses in Ontario in
terms of sex, geographic region, age at diagnosis, and
HIV exposure category [16]; however, they under-
represent the recently diagnosed and include only those
successfully linked to HIV care. Compared to non-OCS
clinic patients, participants tend to be older, were diag-
nosed in the more distant past, and are generally
healthier as measured by CD4 cell count and viral load
[23]. Altogether, we believe that the true value for the
rate of syphilis infection (rather than diagnosis) among
all HIV-positive MSM in Ontario was higher than what
we observed.
Regional and temporal patterns in the cohort mimicked
provincial findings in the general male population from
notifiable disease surveillance [1, 8]. The year-to-year rate
changes we observed were consistent with those reported
overall in Ontario. Moreover, rates in the cohort were high-
est among men living in Toronto and Ottawa, as expected
according to provincial case reports [1, 8]. (It should be
noted, however, that syphilis diagnosis rates were non-
negligible outside of these cities at 0.8 per 100 person-years
(95 % CI 0.4, 1.4)). Our estimates were relatively robust to
varying definitions of re-diagnosis. In sum, these consisten-
cies suggest that the laboratory-based case definitions we
used may be adequate for monitoring trends in syphilis co-
infection among HIV-positive MSM and for determining
whether public health interventions produce rate decreases
in this population.
Men with HIV who experience a syphilis diagnosis may re-
quire additional supports to prevent re-infection and greater
vigilance to diagnose it according to our findings and those
of others. First diagnosis occurred at a rate of 2.7 per 100
person-years (95 % CI 1.7, 2.4) whereas re-diagnoses oc-
curred at a rate of 4.8 per 100 person-years (95 % CI 3.7,
5.5), such that men with a previous documented history of
syphilis infection were 3.5 times more likely to have a new
diagnosis according to our multivariable model. Treatment
of syphilis results in loss of protective immunity and resus-
ceptibility to infection [24]. Although we cannot entirely
rule out treatment failure, we believe that the majority
of re-diagnoses were re-infections given our case defi-
nitions and standards of care for syphilis treatment for
HIV patients [6]. Among syphilis case reports, history of
previous infection was more common among HIV-positive
than HIV-negative individuals in British Columbia and in
Ontario [8, 14, 15], and a similarly high rate of re-diagnosis,
at 2 per 100 person-years, was documented in British
Columbia [15]. Future research should explore underlying
causes of heightened risk for re-infection. Hypothesized ex-
planations include ongoing risk behaviour, perhaps due tobeliefs that syphilis is a minor health problem (thus little
concern regarding re-infection). Nevertheless, in our co-
hort, 78 % of new syphilis diagnoses were among men with-
out laboratory evidence of past syphilis infection,
suggesting only moderate concentration of ongoing risk
among men with past infection.
New syphilis diagnoses were most common among
young men at a rate of 9.5 per 100 person-years (95 %
CI 6.6, 13.7) for those under the age of 30. Declining risk
with age is a common feature of STI epidemiology
among HIV-positive [7, 25–27] and general populations
[1, 2]. Targeting syphilis control interventions only to
young men, however, may miss a substantial number of
new cases. Although diagnoses were three times less
likely among men over the age of 50, they still occurred
at a rate of 1.9 per 100 person-years (95 % CI 1.5, 2.5).
We observed few racial or ethnic differences in syphilis,
with the exception that Indigenous men were less likely to
be diagnosed with syphilis. This is in contrast to findings
from the United States where African American men tend
to have higher rates of syphilis diagnosis compared to
White men [2, 25, 26]. Our sample sizes were small for
race/ethnicity categories other than White; confirmation
with larger samples would be prudent. Nor did we detect
dramatic differences in syphilis diagnosis rates according to
income. Among men with no past history of syphilis, men
with university education were more likely to have a first
diagnosis of syphilis compared to men with high school or
less; however, there were no educational differences in risk
for syphilis re-diagnosis. Similarly, a spatial epidemio-
logic analysis of syphilis-HIV co-infection case rates in
Toronto observed no significant rate differences ac-
cording to neighborhood-level measures of residential
instability, material deprivation, dependency, or ethnic
concentration [14].
After adjustment for sociodemographic characteristics,
syphilis diagnosis rates were equivalent among men who
had or had not initiated antiretroviral treatment and who
did or did not have undetectable viral load. Nevertheless,
men with high CD4 cell counts had lower syphilis diagnosis
rates; this could be a marker for better overall health, differ-
ences in sexual behaviours and networks, or alternatively
may be explained by reverse causation, as CD4 decline has
been noted following syphilis acquisition [28–30].
The acquisition of syphilis among HIV-positive MSM in
our setting suggests that sexual behaviours are occurring
that could allow for HIV transmission to partners. In recent
years, the proportion of men on antiretroviral treatment
and with suppressed viral load has greatly increased in our
cohort [31], and preliminary findings suggest that many
syphilis acquisitions occur during encounters between
HIV-positive men (“poz” sex) [32]; both phenomena would
mitigate the potential risk of onward HIV transmission.
Nevertheless, syphilis co-infection may promote secondary
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hanced at this time [6, 33–35]. HIV viral load is a primary
predictor of infectiousness [36] and it may rise during syph-
ilis co-infection [28, 29], although there is limited evidence
that seminal viral load rises among men successfully treated
with modern antiretroviral regimens [37, 38]. Among syph-
ilis cases in our cohort, one third had plasma viremia of
1,000 copies/mL or higher at the time of syphilis diagnosis;
half of such cases were among men taking antiretroviral
medications. Our group will pursue explanations for these
findings in a future paper, notably whether syphilis co-
infection preceded a rise in viremia, whether ART had been
initiated too recently to have achieved an undetectable VL,
or whether men had suboptimal medication adherence
around the time of syphilis infection and diagnosis.
Conclusions
Our findings have implications for ongoing efforts to
improve gay men’s sexual health. We recommend more
concerted efforts to monitor rates of new syphilis infections
among MSM in Ontario, as such data have been absent in
our setting. The observance of high rates of syphilis among
men with HIV in our cohort may help to mobilize
resources to promote timely testing and treatment, thereby
mitigating syphilis sequelae, health care costs, and onward
spread to sexual partners. If syphilis is detected during its
early stages (<1 year), treatment is an inexpensive single
injection of benzathine penicillin G [6, 39]. Patterns of
syphilis diagnoses in our cohort and among reported cases
in Toronto [14] suggest that the syphilis epidemic is mature
and not restricted to a core region or sociodemographic
group. The co-epidemics of HIV and syphilis are complex
and will likely require multiple, broad-scale approaches
that promote behaviour change, partner notification, and
frequent testing that ensures rapid diagnosis and treatment,
thereby preventing onward transmission [40–42].
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